Youth Prescriptions for GLP-1s are on the Rise
Photo illustration of a group of weight loss injection pens on a weight scale. (Photo by: Michael Siluk/UCG/Universal Images Group via Getty Images)
Airdate: Thursday, November 11, 2026 at 9 am
An estimated one in five U.S. adults has tried a GLP-1 for managing weight loss or diabetes. And now, more kids struggling with obesity are taking the medication, too. Pediatric doctors say early intervention with GLP-1s can prevent lifelong obesity, Type 2 diabetes and high blood pressure but want more research into the effects on developing bodies. We’ll discuss the new medical landscape and how doctors and parents are navigating it.
Guest:
- Dr. Babak Orandi, physician and associate professor in the Departments of Surgery and Medicine, NYU Grossman School of Medicine
- Dr. Sujatha Seetharaman, pediatric endocrinologist, UCSF